Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease

Aim To identify the factors associated with vitamin D status in patients with chronic graft-vs-host disease (cGVHD) and evaluate the association between serum vitamin D (25(OH)D) levels and cGVHD characteristics and clinical outcomes defined by the National Institutes of Health (NIH) criteria. Methods 310 cGVHD patients enrolled in the NIH cGVHD natural history study (clinicaltrials.gov: NCT00092235) were analyzed. Univariate analysis and multiple logistic regression were used to determine the associations between various parameters and 25(OH)D levels, dichotomized into categorical variables: ≤20 and >20 ng/mL, and as a continuous parameter. Multiple logistic regression was used to develop a predictive model for low vitamin D. Survival analysis and association between cGVHD outcomes and 25(OH)D as a continuous as well as categorical variable: ≤20 and >20 ng/mL; <50 and ≥50 ng/mL, and among three ordered categories: ≤20, 20-50, and ≥50 ng/mL, was performed.

[1]  K. Setchell,et al.  Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  Anita Lawitschka,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  P. Oefner,et al.  Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation , 2015, Bone Marrow Transplantation.

[4]  S. Steinberg,et al.  Malnutrition in patients with chronic GVHD , 2014, Bone Marrow Transplantation.

[5]  N. Hamerschlak,et al.  Serum Levels Of Vitamin D In Patients Undergoing Hematopoietic Stem Cell Transplantation , 2013 .

[6]  C. Sempos,et al.  Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. , 2013, The Journal of clinical endocrinology and metabolism.

[7]  J. Ritz,et al.  Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD , 2013, Bone Marrow Transplantation.

[8]  D. Viswanath,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.

[9]  J. Finkelstein,et al.  Prevalence and predictors of vitamin D deficiency in healthy adults. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[10]  A. Schneeweiss,et al.  Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study , 2011, Breast Cancer Research.

[11]  L. Rybicki,et al.  Vitamin D level after allogeneic hematopoietic stem cell transplant. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[13]  D. Gupta,et al.  Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer , 2011, Nutrition journal.

[14]  F. Sánchez-Guijo,et al.  Effect of vitamin D treatment in chronic GVHD , 2011, Bone Marrow Transplantation.

[15]  P. Herzberg,et al.  Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  D. Mulrooney,et al.  Vitamin D status among long-term survivors of hematopoietic cell transplantation , 2010, Bone Marrow Transplantation.

[17]  N. Leidy,et al.  Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD) , 2010, Bone Marrow Transplantation.

[18]  R. Hayes,et al.  Long-term Variation in Serum 25-Hydroxyvitamin D Concentration among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[19]  Y. Shoenfeld,et al.  The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease , 2009, Nature Clinical Practice Rheumatology.

[20]  M. Holick,et al.  Vitamin D deficiency: a worldwide problem with health consequences. , 2008, The American journal of clinical nutrition.

[21]  G. Vogelsang,et al.  Chronic graft versus host disease , 2004, British journal of haematology.

[22]  E. Cook,et al.  Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  M. Koopman,et al.  A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? , 1999, Journal of internal medicine.

[24]  M. Emoto,et al.  Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. , 1999, Kidney international.

[25]  Alan Agresti,et al.  Categorical Data Analysis , 2003 .

[26]  Nitin R. Patel,et al.  A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables , 1983 .

[27]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[28]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[29]  D. Bikle.  Nonclassic actions of vitamin D. , 2009, The Journal of clinical endocrinology and metabolism.

[30]  P. Lachenbruch,et al.  Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[31]  M. Turner,et al.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  F. Ottery,et al.  Definition of standardized nutritional assessment and interventional pathways in oncology. , 1996, Nutrition.

[33]  M. Prummel,et al.  Effect of prednisone on renal function in man. , 1993, Nephron.

[34]  Prediction of creatinine clearance. , 1978, American journal of hospital pharmacy.